Melanoma Patients Who Fail Standard Meds May Have Another Option
THURSDAY, Dec. 8, 2022 (HealthDay News) — An experimental therapy that uses the body’s own immune system cells may beat a standard treatment for patients with advanced melanoma, a new clinical trial finds. Researchers found that the therapy doubled the amount of time melanoma patients lived without their skin cancerContinue Reading